Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments

Por Mukherjee, Nabanita, Almeida, Adam, Partyka, Katie A., Lu, Yan, Schwan, Josianna V., Lambert, Karoline, Rogers, Madison, Robinson, William A, Robinson, Steven E, Applegate, Allison J, Amato, Carol M, Luo, Yuchun, Fujita, Mayumi, Norris, David A., Shellman, Yiqun G.
Publicado no Oncotarget (2016)

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma

Por Hintzsche, Jennifer D., Gorden, Nicholas T., Amato, Carol M., Kim, Jihye, Wuensch, Kelsey E., Robinson, Steven E., Applegate, Allison J., Couts, Kasey L., Medina, Theresa M., Wells, Keith R., Wisell, Joshua A., McCarter, Martin D., Box, Neil F., Shellman, Yiqun G., Gonzalez, Rene C., Lewis, Karl D., Tentler, John J., Tan, Aik Choon, Robinson, William A.
Publicado no Melanoma Res (2017)